SEC Form 4 · accession 0001209191-18-009523
JUNIPER PHARMACEUTICALS INC · JNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alicia Secor
Officer — President and CEO · Director
Period of report
Feb 9, 2018
Accepted (ET)
Feb 13, 2018 · 4:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000821995
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 9, 2018 | A | 50,500 | $0.00 | A | 88,225 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2 | $7.90 | Feb 9, 2018 | A | 110,000 | A | — | Feb 9, 2028 | Common stock, $0.01 par value per share | 110,000 | 110,000 | D |
Explanation of responses
- F1This Restricted Stock Unit Award shall vest 25% on each anniversary of the date of grant over 4 years.
- F2The option will be exercisable in 25% increments of the shares on each annual anniversary of the date of the grant.